APLS
Price:
$41.05
Market Cap:
$5.00B
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy (GA) in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases. It also develops EMPAVELI (systemic pegcetacoplan) for the treatment of cold agglutinin disease (CAD), and hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) in hematology; C3 glome...[Read more]
Industry
Biotechnology
IPO Date
2017-11-09
Stock Exchange
NASDAQ
Ticker
APLS
According to Apellis Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.08. This represents a change of 25.21% compared to the average of 4.06 of the last 4 quarters.
The mean historical Current Ratio of Apellis Pharmaceuticals, Inc. over the last ten years is 9.87. The current 5.08 Current Ratio has changed 5.05% with respect to the historical average. Over the past ten years (40 quarters), APLS's Current Ratio was at its highest in in the December 2017 quarter at 27.77. The Current Ratio was at its lowest in in the September 2014 quarter at 0.
Average
9.87
Median
7.33
Minimum
3.10
Maximum
27.77
Discovering the peaks and valleys of Apellis Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 269.25%
Maximum Annual Current Ratio = 27.77
Minimum Annual Increase = -57.18%
Minimum Annual Current Ratio = 3.10
Year | Current Ratio | Change |
---|---|---|
2023 | 3.10 | -27.90% |
2022 | 4.29 | -31.31% |
2021 | 6.25 | -12.55% |
2020 | 7.15 | 25.96% |
2019 | 5.67 | -52.28% |
2018 | 11.89 | -57.18% |
2017 | 27.77 | 269.25% |
2016 | 7.52 | -36.73% |
2015 | 11.89 | -9.76% |
2014 | 13.17 | 71.81% |
The current Current Ratio of Apellis Pharmaceuticals, Inc. (APLS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.55
5-year avg
5.29
10-year avg
9.87
Apellis Pharmaceuticals, Inc.’s Current Ratio is less than Prometheus Biosciences, Inc. (37.56), less than Akero Therapeutics, Inc. (24.89), less than Immunovant, Inc. (13.08), less than Madrigal Pharmaceuticals, Inc. (8.72), greater than Day One Biopharmaceuticals, Inc. (4.09), less than Mirati Therapeutics, Inc. (7.54), greater than Amylyx Pharmaceuticals, Inc. (4.66), less than Terns Pharmaceuticals, Inc. (21.02), less than X4 Pharmaceuticals, Inc. (6.07), less than Inozyme Pharma, Inc. (9.84), less than Mereo BioPharma Group plc (6.07), greater than Blueprint Medicines Corporation (3.71), less than Cerevel Therapeutics Holdings, Inc. (10.22), less than Acumen Pharmaceuticals, Inc. (17.37),
Company | Current Ratio | Market cap |
---|---|---|
37.56 | $9.56B | |
24.89 | $1.83B | |
13.08 | $4.98B | |
8.72 | $5.30B | |
4.09 | $1.25B | |
7.54 | $4.12B | |
4.66 | $161.36M | |
21.02 | $549.60M | |
6.07 | $109.78M | |
9.84 | $312.42M | |
6.07 | $664.26M | |
3.71 | $5.47B | |
10.22 | $8.19B | |
17.37 | $133.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Apellis Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Apellis Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Apellis Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for Apellis Pharmaceuticals, Inc. (APLS)?
What is the highest Current Ratio for Apellis Pharmaceuticals, Inc. (APLS)?
What is the 3-year average Current Ratio for Apellis Pharmaceuticals, Inc. (APLS)?
What is the 5-year average Current Ratio for Apellis Pharmaceuticals, Inc. (APLS)?
How does the current Current Ratio for Apellis Pharmaceuticals, Inc. (APLS) compare to its historical average?